What is histogenics'stock price?
Histogenics trades on the NASDAQ under the ticker symbol "HSGX." What is Histogenics' stock price today? One share of HSGX stock can currently be purchased for approximately $4.16.
Is histogenics Corporation’s stock down 4 days in a row?
The Histogenics Corporation stock price fell by -4.56% on the last day (Thursday, 20th Jan 2022) from $3.73 to $3.56. and has now fallen 4 days in a row. During the day the stock fluctuated 8.32% from a day low at $3.55 to a day high of $3.84. The price has fallen in 7 of the last 10 days and is down by -14.83% for this period.
Does histogenics boast high insider ownership?
In the past three months, Histogenics insiders have not sold or bought any company stock. 19.70% of the stock of Histogenics is held by insiders. A high percentage of insider ownership can be a sign of company health. 40.35% of the stock of Histogenics is held by institutions.
What does histogenics Corporation do?
Sign-up to receive the latest news and ratings for Histogenics and its competitors with MarketBeat's FREE daily newsletter. Histogenics Corporation develops restorative cell therapies that would offer rapid-onset pain relief and restored function. The company was founded in 2000 and is headquartered in Waltham, Massachusetts.
Should I buy histogenics stock?
Is Histogenics Corporation stock A Buy? Histogenics Corporation holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Why did histogenics stock drop?
Histogenics itself highlights the risks involved in small-cap biotech. In 2018, its NeoCart biologic the primary endpoint of its own Phase III trial. Shares fell 72% on the news, and kept falling after Histogenics decided to suspend development of the product in December 2018.
Will OCGN go back up?
Long-term Ocugen stock forecast 2022-2025 Algorithm-based forecasting service Wallet Investor gave a positive OCGN stock price forecast. The site predicted that the share price could climb over the next year, to $7.2 by March 2023.
Did OCGN reverse split?
The split for OCGN took place on September 30, 2019. This was a 1 for 60 reverse split, meaning for each 60 shares of OCGN owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 16.6666666666667 share position following the split.
How were Histogenics' earnings last quarter?
Histogenics Corp (NASDAQ:HSGX) issued its quarterly earnings data on Thursday, August, 9th. The biotechnology company reported ($0.13) earnings per...
Who are Histogenics' key executives?
Histogenics' management team includes the following people: Mr. Adam D. Gridley , Interim Pres, CEO Treasurer, Sec., Consultant & Director (Age...
Who are some of Histogenics' key competitors?
Some companies that are related to Histogenics include Inogen (INGN) , Vicarious Surgical (RBOT) , Sanara MedTech (SMTI) , Lakeland Industries...
What other stocks do shareholders of Histogenics own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Histogenics investors own include Interpace Biosciences (I...
When did Histogenics IPO?
(HSGX) raised $60 million in an IPO on Wednesday, December 3rd 2014. The company issued 4,300,000 shares at a price of $13.00-$15.00 per share. Cow...
What is Histogenics' stock symbol?
Histogenics trades on the NASDAQ under the ticker symbol "HSGX."
What is Histogenics' stock price today?
One share of HSGX stock can currently be purchased for approximately $2.49.
How much money does Histogenics make?
Histogenics (NASDAQ:HSGX) has a market capitalization of $235.55 million. The biotechnology company earns $-8.64 million in net income (profit) eac...
How many employees does Histogenics have?
Histogenics employs 49 workers across the globe.
What is histogenics corp?
How much did histogenics stock fall in 2021?
Histogenics Corporation, a regenerative medicine company, focuses on developing and commercializing products in the musculoskeletal segment of the marketplace. Its product candidate includes NeoCart, which is in Phase III clinical trials, intended to treat tissue injury in the field of orthopedics, specifically cartilage damage in the knee. The company has an exclusive channel collaboration agreement with Intrexon Corporation for the development ... Read more
Is Histogenics oversold on RSI?
The Histogenics Corporation stock price fell by -3.07% on the last day (Friday, 9th Jul 2021) from $7.50 to $7.27. During the day the stock fluctuated 4.79% from a day low at $7.13 to a day high of $7.47. The price has fallen in 6 of the last 10 days and is down by -11.02% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -11 million shares and in total, 13 million shares were bought and sold for approximately $96.80 million.
Is Bollinger Band stock high risk?
Histogenics Corporation is oversold on RSI14 (14). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.
Is histogenics stock negative?
This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $1.18 between high and low, or 19.70%. For the last week, the stock has had a daily average volatility of 10.35% .
Does histogenics stock have a sell signal?
The Histogenics Corporation stock holds several negative signals and despite the positive trend, we believe Histogenics Corporation will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.
Is Histogenics Corporation stock A Buy?
Also, there is a general sell signal from the relation between the two signals where the long- term average is above the short-term average.